137 related articles for article (PubMed ID: 27306805)
1. [Genetic Mutation Accumulation and Clinical Outcome of Immune Checkpoint Blockade Therapy].
Takahashi M
Gan To Kagaku Ryoho; 2016 Jun; 43(6):678-82. PubMed ID: 27306805
[TBL] [Abstract][Full Text] [Related]
2. [Recent Development of Therapies for Melanoma Using Immune Checkpoint Blockades].
Okuyama R
Gan To Kagaku Ryoho; 2016 Jun; 43(6):661-5. PubMed ID: 27306802
[TBL] [Abstract][Full Text] [Related]
3. [Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) in cancer therapy].
Hatae R; Chamoto K
Rinsho Ketsueki; 2016; 57(10):2224-2231. PubMed ID: 27795534
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.
Ott PA; Hodi FS; Robert C
Clin Cancer Res; 2013 Oct; 19(19):5300-9. PubMed ID: 24089443
[TBL] [Abstract][Full Text] [Related]
5. Programmed death-1 & its ligands: promising targets for cancer immunotherapy.
Shrimali RK; Janik JE; Abu-Eid R; Mkrtichyan M; Khleif SN
Immunotherapy; 2015; 7(7):777-92. PubMed ID: 26250412
[TBL] [Abstract][Full Text] [Related]
6. The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Shin DS; Ribas A
Curr Opin Immunol; 2015 Apr; 33():23-35. PubMed ID: 25621841
[TBL] [Abstract][Full Text] [Related]
7. [Targeting the PD-1/PD-L1 immune checkpoint signal - a new treatment strategy for cancer].
Hamanishi J; Konishi I
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1071-6. PubMed ID: 25248890
[TBL] [Abstract][Full Text] [Related]
8. Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.
Czink E; Kloor M; Goeppert B; Fröhling S; Uhrig S; Weber TF; Meinel J; Sutter C; Weiss KH; Schirmacher P; Doeberitz MVK; Jäger D; Springfeld C
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28619747
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint therapy for non-small-cell lung cancer: an update.
Xia B; Herbst RS
Immunotherapy; 2016; 8(3):279-98. PubMed ID: 26860624
[TBL] [Abstract][Full Text] [Related]
10. Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.
Gentzler R; Hall R; Kunk PR; Gaughan E; Dillon P; Slingluff CL; Rahma OE
Immunotherapy; 2016 May; 8(5):583-600. PubMed ID: 27140411
[TBL] [Abstract][Full Text] [Related]
11. Cancer Mutational Load: The More the Merrier for Immune Checkpoint Blockade Therapies.
EBioMedicine; 2016 Nov; 13():1-2. PubMed ID: 27916137
[No Abstract] [Full Text] [Related]
12. Are virus-induced cancers more sensitive to checkpoint inhibitors?
Kanaan H; Kourie HR; Awada AH
Future Oncol; 2016 Dec; 12(23):2665-2668. PubMed ID: 27513334
[No Abstract] [Full Text] [Related]
13. Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy.
Hamid O; Carvajal RD
Expert Opin Biol Ther; 2013 Jun; 13(6):847-61. PubMed ID: 23421934
[TBL] [Abstract][Full Text] [Related]
14. [Era of cancer immunotherapy has come].
Nakatsura T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):164-71. PubMed ID: 27320931
[TBL] [Abstract][Full Text] [Related]
15. The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation.
Blank CU
Curr Opin Oncol; 2014 Mar; 26(2):204-14. PubMed ID: 24424272
[TBL] [Abstract][Full Text] [Related]
16. Emerging immunotherapies in the treatment of non-small cell lung cancer (NSCLC): the role of immune checkpoint inhibitors.
Langer CJ
Am J Clin Oncol; 2015 Aug; 38(4):422-30. PubMed ID: 24685885
[TBL] [Abstract][Full Text] [Related]
17. Immune Checkpoint Blockade in Cancer Therapy.
Postow MA; Callahan MK; Wolchok JD
J Clin Oncol; 2015 Jun; 33(17):1974-82. PubMed ID: 25605845
[TBL] [Abstract][Full Text] [Related]
18. PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer.
Bagley SJ; Bauml JM; Langer CJ
Clin Adv Hematol Oncol; 2015 Oct; 13(10):676-83. PubMed ID: 27058572
[TBL] [Abstract][Full Text] [Related]
19. [Immune Checkpoint Inhibitors for Advanced Melanoma - Evidences and Future Perspectives].
Nakamura Y; Teramoto Y; Asami Y; Matsuya T; Yamamoto A
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1036-40. PubMed ID: 27628544
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitors in lung cancer: past, present and future.
Seetharamu N; Budman DR; Sullivan KM
Future Oncol; 2016 May; 12(9):1151-63. PubMed ID: 27019997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
